Provision of technical assistance to manufacturers of generic family planning products
Under its ongoing Bill and Melinda Gates Foundation (BMGF) grant to address the barriers to making quality-assured, three-monthly injectable contraception widely available, Concept Foundation is working with manufacturers of generic intra-muscular depot medroxyprogesterone acetate (DMPA) FPPs and medroxyprogesterone acetate (MPA) APIs towards achieving WHO Prequalification (PQ) of their products. (More information on WHO PQ can be found on our Resources page)
Technical support is being provided to manufacturers of MPA API to ensure that adequately documented quality ingredients are available to manufacturers of generic DMPA, in order to both support WHO PQ and ultimately serve the market. In addition to these activities, Concept Foundation has continued working with selected oral contraceptive manufactures, however due to a lack of donor funding for this activity, agreements have been made with the manufacturers to receive technical assistance on a fee paying basis.
Technical assistance is provided as follows: